✓Medically Reviewed by Dr. Şekip Altunkan on Nov 21, 2026.
Image generated by AI · VitalsDaily
Key Takeaway
A 2026 scientific statement from the American College of Cardiology urges physicians to evaluate cholesterol risk through the lens of lifelong cumulative exposure rather than a narrow 10-year snapshot. The statement advocates for earlier, more decisive cholesterol lowering in high-risk individuals, leveraging coronary artery calcium screening and inherited risk factors to identify patients overlooked by conventional risk calculators.
The 38-Year-Old Patient the Calculator Considers Safe
Consider a 38-year-old software engineer we will call Marcus. He runs three days a week, does not smoke, and maintains blood pressure numbers that most adults would envy. Yet his low-density lipoprotein (LDL) cholesterol—commonly known as “bad” cholesterol—hovers around 165 mg/dL, and his father suffered a myocardial infarction at just 52. When evaluated using traditional clinical tools, these parameters offer the clinician surprisingly little direction. While the 2019 primary prevention guidelines focused formal risk estimation on adults aged 40 to 75, the updated 2026 ACC/AHA Dyslipidemia Guideline expanded this threshold down to age 30, introducing the PREVENT-ASCVD equations to project both 10-year and 30-year risk in clinical practice[1], [2]. However, even these modern equations capture only a single cross-sectional snapshot in time; they cannot directly gauge when cholesterol elevation began or how many cumulative years the arterial wall has weathered this burden. Indeed, analyses of more than 270,000 adults aged 20 to 39 demonstrate that the PREVENT-ASCVD equations can still substantially underestimate true 30-year cardiovascular risk[1]. Viewed through a 10-year lens, a fit man in his late 30s will almost invariably appear low risk.
Yet the calculator, while technically accurate, is clinically myopic. Ten years…
ŞA
Medically reviewed by
Dr. Şekip Altunkan
Dr. Şekip Altunkan is an internal medicine specialist with extensive clinical experience. He trained at Hacettepe University Faculty of Medicine and later served as an Associate Professor in Internal Medicine. He founded and led the Metropol Internal Medicine and Hypertension Clinic in Ankara, pioneering non-invasive Electron Beam Tomography (EBT) cardiac imaging, arterial-stiffness measurement, and nationwide Holter monitoring. He currently practices at his private clinic in Ankara, focusing on hypertension, vascular health, cholesterol, diabetes and heart disease. He has published widely in national and international journals, serves as a peer reviewer for several international journals, and is the author of the book "Questions and Answers on Hypertension."